MXPA97007140A - New topic compositions under the form of fluid emulsion of oil in water with great content of glycol pro-penetra - Google Patents
New topic compositions under the form of fluid emulsion of oil in water with great content of glycol pro-penetraInfo
- Publication number
- MXPA97007140A MXPA97007140A MXPA/A/1997/007140A MX9707140A MXPA97007140A MX PA97007140 A MXPA97007140 A MX PA97007140A MX 9707140 A MX9707140 A MX 9707140A MX PA97007140 A MXPA97007140 A MX PA97007140A
- Authority
- MX
- Mexico
- Prior art keywords
- weight
- composition according
- agents
- composition
- respect
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 30
- 239000000839 emulsion Substances 0.000 title claims abstract description 20
- 239000012530 fluid Substances 0.000 title claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 23
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 11
- 230000000699 topical Effects 0.000 claims abstract description 7
- 229920000642 polymer Polymers 0.000 claims description 18
- 230000000149 penetrating Effects 0.000 claims description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 8
- 125000000129 anionic group Chemical group 0.000 claims description 7
- 238000004132 cross linking Methods 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 7
- 239000003921 oil Substances 0.000 claims description 7
- -1 radicals acrylates Chemical class 0.000 claims description 7
- 239000000178 monomer Substances 0.000 claims description 6
- 239000012071 phase Substances 0.000 claims description 4
- WXZMFSXDPGVJKK-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 3
- 229940088710 Antibiotic Drugs 0.000 claims description 3
- 230000000844 anti-bacterial Effects 0.000 claims description 3
- 230000000843 anti-fungal Effects 0.000 claims description 3
- 229940121375 antifungals Drugs 0.000 claims description 3
- 239000008346 aqueous phase Substances 0.000 claims description 3
- 239000003349 gelling agent Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- XXJWXESWEXIICW-UHFFFAOYSA-N 2-(2-Ethoxyethoxy)ethanol Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims description 2
- SGRCVQDBWHCTIS-UHFFFAOYSA-N 2-nonanoyloxypropyl nonanoate Chemical compound CCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCC SGRCVQDBWHCTIS-UHFFFAOYSA-N 0.000 claims description 2
- 229940100197 ANTIMETABOLITES Drugs 0.000 claims description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N Dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 2
- 206010062080 Pigmentation disease Diseases 0.000 claims description 2
- 201000004384 alopecia Diseases 0.000 claims description 2
- 230000000340 anti-metabolite Effects 0.000 claims description 2
- 230000002141 anti-parasite Effects 0.000 claims description 2
- 230000002421 anti-septic Effects 0.000 claims description 2
- 239000002256 antimetabolite Substances 0.000 claims description 2
- 239000003096 antiparasitic agent Substances 0.000 claims description 2
- 239000003908 antipruritic agent Substances 0.000 claims description 2
- 239000003443 antiviral agent Substances 0.000 claims description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 2
- 239000007957 coemulsifier Substances 0.000 claims description 2
- 230000004069 differentiation Effects 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- 239000003193 general anesthetic agent Substances 0.000 claims description 2
- 230000003676 hair loss Effects 0.000 claims description 2
- 230000002209 hydrophobic Effects 0.000 claims description 2
- 239000003410 keratolytic agent Substances 0.000 claims description 2
- 230000000051 modifying Effects 0.000 claims description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims description 2
- 230000035755 proliferation Effects 0.000 claims description 2
- 239000002294 steroidal antiinflammatory agent Substances 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 239000000058 anti acne agent Substances 0.000 claims 1
- 230000002225 anti-radical Effects 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- CBGUOGMQLZIXBE-XGQKBEPLSA-N Clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 229920001888 polyacrylic acid Polymers 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 229960004703 Clobetasol Propionate Drugs 0.000 description 3
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N benzohydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol;(Z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18β-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 description 2
- 229960003913 Econazole Drugs 0.000 description 2
- LEZWWPYKPKIXLL-UHFFFAOYSA-N Econazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N Kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N Oleyl alcohol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- BTSZTGGZJQFALU-UHFFFAOYSA-N Piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 2
- 229920001083 Polybutene Polymers 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N Simethicone Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- 229940001017 Temovate Drugs 0.000 description 2
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 2
- 229960001727 Tretinoin Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 2
- PBOSTUDLECTMNL-UHFFFAOYSA-N dodecyl prop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drugs Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229950001046 piroctone Drugs 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Acrylamido-2-methylpropane sulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
- WROUWQQRXUBECT-UHFFFAOYSA-N 2-ethylacrylic acid Chemical compound CCC(=C)C(O)=O WROUWQQRXUBECT-UHFFFAOYSA-N 0.000 description 1
- GTRGFUCVDQMYKO-UHFFFAOYSA-N 2-hydroxyethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCO GTRGFUCVDQMYKO-UHFFFAOYSA-N 0.000 description 1
- AUZRCMMVHXRSGT-UHFFFAOYSA-N 2-methylpropane-1-sulfonic acid;prop-2-enamide Chemical compound NC(=O)C=C.CC(C)CS(O)(=O)=O AUZRCMMVHXRSGT-UHFFFAOYSA-N 0.000 description 1
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 1
- COCLLEMEIJQBAG-UHFFFAOYSA-N 8-methylnonyl 2-methylprop-2-enoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)=C COCLLEMEIJQBAG-UHFFFAOYSA-N 0.000 description 1
- 229940023040 Acyclovir Drugs 0.000 description 1
- 241000272519 Aix Species 0.000 description 1
- ZZHLYYDVIOPZBE-UHFFFAOYSA-N Alimemazine Chemical compound C1=CC=C2N(CC(CN(C)C)C)C3=CC=CC=C3SC2=C1 ZZHLYYDVIOPZBE-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- RZVHIXYEVGDQDX-UHFFFAOYSA-N Anthraquinone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 RZVHIXYEVGDQDX-UHFFFAOYSA-N 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940064004 Antiseptic throat preparations Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N BRL-49594 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- SNHRLVCMMWUAJD-SUYDQAKGSA-N Betamethasone 17-valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 description 1
- 229960004311 Betamethasone valerate Drugs 0.000 description 1
- 229910014033 C-OH Inorganic materials 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N Cetyl alcohol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229940085262 Cetyl dimethicone Drugs 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N Cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- DNTGGZPQPQTDQF-XBXARRHUSA-N Crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 1
- JJCFRYNCJDLXIK-UHFFFAOYSA-N Cyproheptadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 JJCFRYNCJDLXIK-UHFFFAOYSA-N 0.000 description 1
- 229960001140 Cyproheptadine Drugs 0.000 description 1
- 229910014570 C—OH Inorganic materials 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Chemical class CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- 229960005309 Estradiol Drugs 0.000 description 1
- 229940011871 Estrogens Drugs 0.000 description 1
- 229940073144 Glycyrrhetinic acid Drugs 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 229940093915 Gynecological Organic acids Drugs 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N Hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Incidol Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N Ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 229960000448 Lactic acid Drugs 0.000 description 1
- 229960004393 Lidocaine Hydrochloride Drugs 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N Malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229960000282 Metronidazole Drugs 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 description 1
- 229940100460 PEG-100 Stearate Drugs 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 240000008426 Persea americana Species 0.000 description 1
- 229940066842 Petrolatum Drugs 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229940068965 Polysorbates Drugs 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- RJKFOVLPORLFTN-STHVQZNPSA-N Progesterone Natural products O=C(C)[C@@H]1[C@@]2(C)[C@H]([C@H]3[C@@H]([C@]4(C)C(=CC(=O)CC4)CC3)CC2)CC1 RJKFOVLPORLFTN-STHVQZNPSA-N 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 229940030484 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM ESTROGENS Drugs 0.000 description 1
- 229940057429 SORBITAN ISOSTEARATE Drugs 0.000 description 1
- 210000004761 Scalp Anatomy 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229960005078 Sorbitan sesquioleate Drugs 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N Squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N Stearyl alcohol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide Dismutase Proteins 0.000 description 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Syngestrets Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N Terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N Tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- 229940035740 Trimeprazine Drugs 0.000 description 1
- 229940029983 VITAMINS Drugs 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 229940046008 Vitamin D Drugs 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 1
- 229940045860 White wax Drugs 0.000 description 1
- OTPSWLRZXRHDNX-UHFFFAOYSA-L Zinc pyrithione Chemical compound S1C2=CC=CC=N2=O[Zn]21O=N1=CC=CC=C1S2 OTPSWLRZXRHDNX-UHFFFAOYSA-L 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1R)-1-[(2S,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2R)-2-[(3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 1
- UFUVLHLTWXBHGZ-MGZQPHGTSA-N [(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](OP(O)(O)=O)[C@@H](SC)O1 UFUVLHLTWXBHGZ-MGZQPHGTSA-N 0.000 description 1
- NYHKQIDQAAXQSX-UHFFFAOYSA-N [dimethyl(octyl)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound CCCCCCCC[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C NYHKQIDQAAXQSX-UHFFFAOYSA-N 0.000 description 1
- PDWFFEHBPAYQGO-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-hexyl-dimethylsilane Chemical compound CCCCCC[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C PDWFFEHBPAYQGO-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N acyclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 230000000996 additive Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960003790 alimemazine Drugs 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940087168 alpha Tocopherol Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960003942 amphotericin B Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 230000000111 anti-oxidant Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000010477 apricot oil Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- WPKYZIPODULRBM-UHFFFAOYSA-N azane;prop-2-enoic acid Chemical compound N.OC(=O)C=C WPKYZIPODULRBM-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogens Species 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 229960002291 clindamycin phosphate Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000295 complement Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229960003338 crotamiton Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- GUOJYIXWHMJFDM-UHFFFAOYSA-N decan-2-yl prop-2-enoate Chemical compound CCCCCCCCC(C)OC(=O)C=C GUOJYIXWHMJFDM-UHFFFAOYSA-N 0.000 description 1
- GTBGXKPAKVYEKJ-UHFFFAOYSA-N decyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C(C)=C GTBGXKPAKVYEKJ-UHFFFAOYSA-N 0.000 description 1
- FWLDHHJLVGRRHD-UHFFFAOYSA-N decyl prop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C=C FWLDHHJLVGRRHD-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229940046080 endocrine therapy drugs Estrogens Drugs 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- HMZGPNHSPWNGEP-UHFFFAOYSA-N octadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)=C HMZGPNHSPWNGEP-UHFFFAOYSA-N 0.000 description 1
- FSAJWMJJORKPKS-UHFFFAOYSA-N octadecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C=C FSAJWMJJORKPKS-UHFFFAOYSA-N 0.000 description 1
- 125000005474 octanoate group Chemical class 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002889 oleic acids Chemical class 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000005426 persea americana Nutrition 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002335 preservative Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N rac-1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 230000002207 retinal Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000000475 sunscreen Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- USFMMZYROHDWPJ-UHFFFAOYSA-N trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium Chemical compound CC(=C)C(=O)OCC[N+](C)(C)C USFMMZYROHDWPJ-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229930003231 vitamins Natural products 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Abstract
The present invention relates to a new composition in the form of a fluid emulsion of the oil in water (A / A) type for a topical application, comprising between 30 to 50% by weight with respect to the total weight of the composition of minus one glycol, an appropriate emulsifier system and at least one active agent. The fluid composition according to the invention preferably has a viscosity comprised between 3 and 10 Pa.s (3000 and 10000, centipoise), viscosity measured with a Brookfield apparatus model LVDV II + mobile no. 4, with a speed of 30 turns / mn for 30 seconds and a temperature of 25øC +/- 3
Description
NEW TOPICAL COMPOSITIONS UNDER THE FORM OF EMULSION FLUID OF OIL IN WATER WITH GREAT CONTENT OF GLYCOL PRO-PENETRATING.
FIELD OF THE INVENTION The present invention relates to a new composition in the form of a fluid emulsion of the oil in water (A / A) type for a topical application, comprising a high content of at least one pro-penetrating glycol, an appropriate emulsion system and an active agent.
BACKGROUND OF THE INVENTION There are currently a large number of topical compositions comprising an active agent and a high content of glycol, the latter favors the penetration of the active agent into the skin. Taking into account the high content of pro-penetrating glycol, these compositions are formulated in the form of emulsions with a high content of fatty phase which are commonly called "lipocremas", in the form of anhydrous compositions which are called "ointments", under the form of fluid compositions with a high content of volatile solvents, such as ethanol or isopropanol, intended for applications on the scalp,
REF: 25679 also called "hair lotions", or even in the form of viscous A / A emulsions, which are also called "A / A creams". For example, A / A creams comprising a corticoid and a large percentage of propylene glycol (47.5%) marketed under the trademark TEMOVATE by the company GLAXO are known. Now, the stabilization of a formulation comprising such percentage of glycol makes it necessary to use in the emulsion of emulsifying and stabilizing agents of the glycerol stearate or PEG 100 stearate type or even of stabilizing agents or consistency factors of the white wax or alcohol type. cetostearyl which lead to the formation of a viscous cream, ie, where the viscosity is greater than 10 Pa.s (10000 centipoise, measured with a Brookfield model LVDV II + mobile No. 4, at a speed of 30 rounds / min for 30 seconds and at a temperature of 25 ° C +/- 3 ° C). To facilitate the application of topical compositions comprising a strong or large percentage of glycol, it is interesting to have a new stable formulation of the type of emulsion A / A, where the viscosity is intermediate between the most fluid hair lotions and a very limited use , and the more viscous A / C creams and have a greasy and sticky side, always preserving the pro-penetrating properties of glycol.
DESCRIPTION OF THE INVENTION The present invention then relates to a new composition in the form of a fluid emulsion of the oil in water (A / A) type for a topical application, comprising between 30 to 50% by weight with respect to the total weight of the composition of at least one glycol, an appropriate emulsifier system and at least one active agent. By fluid emulsion, it is advantageously understood an emulsion where the viscosity is between 3 and 10 Pa.s (3000 and 10000 centipoise), viscosity measured with a Brookfield apparatus model LVDV II + mobile no. 4, at a speed of 30 turns / min for 30 seconds and at a temperature of 25 ° C +/- 3 ° C. Advantageously, a stable emulsion according to the invention is obtained by selecting as an appropriate emulsifier system at least one polymer emulsion. Polymer emulsions are especially described by CLYMANS & BRAND in "Cosmetics and Toiletries" (Manufacture Worldwide, 1995, 119-125), in particular anionic amphiphilic polymers, more particularly those comprising at least one hydrophilic portion of the olefinic unsaturated carboxylic acid type, and at least one hydrophobic portion of the C10-C30 alkyl ester type According to the invention, it is understood to designate by acrylic portions the portions of the formula: CH2 = C-C-OH Ri 0 in which Ri denotes H or CH3 or C2H5, ie the portions of Acrylic acid, methacrylic acid or ethacrylic acid It is also understood to designate by portions of alkyl acrylates the portions of the structure:
CH2 = C-C-OR2 I if Ra O in which Ri designates H or CH3 or C2H5, that is to say the radicals or portions of acrylates, methacrylates or ethacrylates, R2 denotes an alkyl radical of C? 0-C30, preferably of C? 2-C22. The acrylates according to the invention comprise, for example, lauryl acrylate, stearyl acrylate, decyl acrylate, isodecyl acrylate, dodecyl acrylate and corresponding methacrylates, lauryl methacrylate, stearyl methacrylate, decyl methacrylate, isodecyl methacrylate and dodecyl methacrylate. Preferably, the following anionic amphiphilic polymers are crosslinked with a polymerizable crosslinking monomer, which contains a group CH2 = C < with at least one other polymerizable group where the unsaturated bonds are not conjugated with respect to each other. Polymerizable crosslinking monomers of the type are, for example, and preferably polyallyl ethers, such as especially polyallylsucrose and polyallyl pentaerythritol. Crosslinked polymers of this type are well known; they are especially described in US Pat. Nos. 3,915,921 and 4,509,949. According to the invention, it is more particularly possible to use as anionic amphiphilic polymers, (i) those which are composed of 95 to 60% by weight of acrylic radicals, 4 to 40% by weight of acrylate radicals and from 0.1 to 6% by weight of crosslinking monomer, or (ii) those which are comprised of 98 to 96% by weight of acrylic radicals, from 1 to 4% by weight of acrylate radicals and from 0.1 to 0.6% by weight of crosslinking monomer.
Among said crosslinked polymers mentioned below, the products sold by the company are more particularly preferred according to the present invention.
GOODRICH under the trade names PEMULEN TRI, PEMULEN TR2, CARBOPOL 1342, or CARBOPOL 1382. The composition according to the invention advantageously comprises up to 1% by weight of the appropriate emulsifier system, preferably between 0.2 and 0.4% by weight, based on the total weight of the composition. The pro-penetrating glycol is advantageously chosen from propylene glycol, dipropylene glycol, propylene glycol dipelargonate, lauroglycol or ethoxydiglycol. Preferably, the composition according to the invention comprises between 40 and 50% by weight of pro-penetrating glycol. Among the active agents, mention may be made, for example, of agents that modulate differentiation and / or proliferation and / or skin pigmentation such as retinoic acid and its isomers, retinol and its esters, retinal, retinoids, especially those described in patent applications FR 2 570 377, EP 199 636, EP 325 540, EP 402 072, vitamin D and its derivatives, estrogens such as estradiol, kojic acid or hydroquinone; antibacterials such as clindamycin phosphate, erythromycin or antibiotics of the tetracycline class; antiparasitics, in particular metronidazole, crotamiton or pyrethrinoids; antifungals, in particular compounds belonging to the class of imidazoles such as econazole, ketoconazole or miconazole or their salts, polyene compounds, such as amphotericin B, compounds of the allyase family, such as terbinafine, or even octopirox; steroidal antiinflammatory agents, such as hydrocortisone, anthralins (dioxanthranol), anthranoids, betamethasone valerate or clobetasol propionate, or non-steroidal anti-inflammatory agents such as ibuprofen or its salts, diclofenac and its salts, acetylsalicylic acid, acetaminophenone or glycyrrhetinic acid; anesthetic agents such as lidocaine hydrochloride and its derivatives: antipruritic agents such as thenaldin, trimeprazine or cyproheptadine; antiviral agents such as acyclovir; keratolytic agents such as alpha- and beta-hydroxycarboxylic or beta-ketocarboxylic acids, their salts, amides or esters and more particularly hydroxy acids such as glycolic acid, lactic acid, malic acid, salicylic acid, citric acid and generally the fruit acids, and the n-octanoyl-5-salicylic acid; free anti-free radicals, such as alpha-tocopherol or its esters, the superoxide dismutases, certain metal chelators or ascorbic acid and their esters; antiseborrheic drugs such as progesterone; antipeliculars such as octopirox or zinc pyrithione; anti-acne drugs such as retinoic acid, benzoyl peroxide or adapalane; the antimetabolites; agents to fight against hair loss such as monoxidil; the antiseptics Advantageously, the composition according to the invention comprises between 0.0001 and 20% by weight with respect to the total weight of the composition of an active agent, preferably between 0.025 and 15% by weight. It will be understood that the amount of active ingredient in the composition according to the invention will depend on the asset considered. Thus, for a steroidal anti-inflammatory, the composition according to the invention will advantageously comprise less than 1% by weight of active agent, preferably between 0.025 and 0.05% by weight. For hydroquinones, the composition according to the invention will preferably comprise between 2 and 5% of active agent. For antibacterials or antifungals such as econazole, the composition according to the invention will preferably comprise between 8 and 10% by weight of active agent. The fatty phase of the emulsion according to the invention can comprise the fatty substances usually used in the domain of the examined application. Among them, mention may be made of silicone fatty substances such as silicone oils, as well as non-silicone fatty substances, such as vegetable, mineral, animal or synthetic oils. Among the silicone fatty substances, we can mention:
(i) polyalkyl (C? -C20) siloxanes and especially those with trimethylsilyl end groups, preferably those where the viscosity is less than 0.06 m2 / s, among which linear polydimethylsiloxanes and alkylmethylpolysiloxanes such as cetyldimethicone can be cited
(name CTFA), B (ii) volatile silicone oils, such as: β cyclic volatile silicones having from 3 to 8 silicon atoms and preferably from 4 to 5. These are, for example, cyclo-tetradimethylsiloxane, cyclopentadi-ethylsiloxane or of the cyclohexadimethylsiloxane.
cyclopolymers of the dimethylsiloxane / methylalkylsiloxane type, such as SILICONE FZ 3109 sold by the company UNION CARBIDE, which is a cyclocopolymer of dimethylsiloxane / methyloctylsiloxane, the linear volatile silicones having from 2 to 9 silicon atoms. It is, for example, hexamethyldisiloxane, hexyl heptamethyltrisiloxane or octyl heptamethyltrisiloxane. (iii) phenylene silicone oils, especially those of the formula:
ual: R is an alkyl radical of C? -C30, an aryl radical or an aralkyl radical, I n is an integer between 0 and 100, B m is an integer between 0 and 100, subject to the sum is between 1 and 100. Among the non-silicone fatty substances, mention may be made of the usual oils, such as paraffin oil, petrolatum, almond oil, perhydrosqualene, apricot oil, wheat germ oil. , sweet almond, calofile, palm, castor, avocado, jojoba, olive or cereal germs; esters of fatty acids or fatty alcohols, such as octyl dodecyl myristate or C2-C15 alkyl benzoates, alcohols; the acetyglycerides; the octanoates, decanoates or ricinoleates of alcohols or polyalcohols; triglycerides of fatty acids; the glycerides; hydrogenated polybutene, hydrogenated oils that solidify at 25 ° C; the lanolins; the fatty esters that solidify at 25 ° C. The fatty substances can in particular be chosen in a manner varied by the person skilled in the art in order to prepare a composition having the desired properties, for example in consistency or texture.
Thus, the fatty phase of the emulsion according to the invention can have a content of between 5 and 50% by weight with respect to the total weight of the composition and preferably comprised between 15 and 25% by weight. The aqueous phase of the emulsion according to the invention may comprise water, a floral water such as cornflower water, or a thermal water or natural mineral, for example chosen from Vittel water, Vichy pond water, water of Uriage, the water of the Roche Posay, the water of Bourboule, the water of Enghien-les Bains, the water of Saint Gervais-les-Bains, the water of Neris-les-Bains, the water of Allevard-les-bains , the water of Digne, the water of Maiziéres, the water of Neyrac-les-Bains, the water of Lons-le-Saunier, the good waters (les Eaux Bonnes), the water of Rochefort, the water of Saint Christau, the water from Fumades and water from Tercis-les bains, Avene water or water from Aix les Bains. Said aqueous phase can be present with a content comprised between 10 and 70% by weight with respect to the total weight of the composition, preferably comprised between 20 and 40% by weight. The pH of the composition according to the invention is advantageously between 5 and 7, preferably between 5.5 and 6.5. It will be adjusted to a desired value by the addition of bases or customary, mineral or organic acids. Otherwise, the composition according to the invention may comprise between 0 and 3% by weight, preferably between 0 and 2% by weight, based on the total weight of the composition, of at least one co-emulsifier which can be chosen from the esters of saturated or unsaturated fatty acids, natural or synthetic, especially oleic acid or (iso) stearic acid, such as the polyglycerol and isostearic acid esters marketed under the trademark LAMEFORM TGI by the company SIDOBRE-SINNOVA HENKEL, the sorbitan isostearate marketed under the trademark ARLACEL 987 by the company ICI, the sorbitan sesquioleate marketed under the trademark ARLACEL 83 by the ICI company, glycol esters and isostearic acid such as PEG-6 isostearate marketed under the brand name OLEPAL ISOSTEARIQUE by the company GATTEFOSSE, the sorbitol and oleic acid esters, such as the polysorbates marketed under the brand name TWEEN by the company ICI company, fatty alcohol ethers, especially oleic alcohol, in particular glycol and oleyl alcohol esters, such as oleths marketed under the brand name BRIJ by the ICI company, oxyethylenated sorbitan monostearate, fatty alcohols such as stearyl alcohol or cetyl alcohol. Furthermore, according to the invention, the composition can comprise at least one gelling agent and / or thickener in the preferential concentrations comprised between 0 and 5% by weight, with respect to the total weight of the composition. The gelling agent and / or thickener can be chosen from: B polysaccharide biopolymers such as xanthan gum, locust bean gum, guar gum, xanthan gum, alginates, modified celluloses such as hydroxyethylcellulose, methylcellulose , hydroxypropylcellulose, hydroxypropylmethylcellulose and carboxymethylcellulose. B synthetic polymers such as polyacrylic acids such as poly (meth) acrylates glyceryl polymers such as HISPAGEL or LUBRAGEL of HISPANO CHEMICAL or GARDIAN, polyvinylpyrrolidone, polyvinyl alcohol, crosslinked polymers of acrylamide and acrylate ammonium such as PAS 5161 or BOZEPOL C from HOECHST, cross-linked polymers of acrylamide and 2-acrylamido-2-methylpropane sulfonic acid partially or totally neutralized such as SEPIGEL 305 from SEPPIC, the cross-linked polymers of acrylamide and methacryloyloxyethyltrimethylammonium such as SALCARE SC 92 from ALLIED COLLOIDS, crosslinked polymers of acrylic acid and alkyl ethers of sucrose or pentaerythritol (carbomers) such as CARBOPOL 910 to 934 from GOODRICH.
The emulsion may further comprise any other additive usually used in the cosmetic or pharmaceutical field, such as antioxidants, dyes, perfumes, essential oils, preservatives, cosmetic actives, moisturizers, vitamins, essential fatty acids, sphingolipids, self-tanning compounds such as DHA, sunscreens, liposoluble polymers, especially hydrocarbons, such as polybutene, polyalkylenes, polyacrylates and silicone polymers compatible with fatty substances. It is understood that the person skilled in the art will be able to choose the one or more possible complementary compounds, and / or their quantity, in such a way that the advantageous properties of the composition according to the invention are not, or substantially are not altered by the proposed additions. These additives can be present in the composition in a proportion of 0 to 10% by weight with respect to the total weight of the composition. The examples of the following formulations make it possible to illustrate the compositions according to the invention, without limiting it in any way. The amounts of the constituents are mentioned in percent by weight with respect to the total weight of the composition.
EXAMPLE 1. Example of formulation according to the invention. Composition% by weight
Purified water is 100 hydroxypropylmethylcellulose 0.10 propylene glycol 47.50 Active agent 0.05 Liquid paraffin 110-230 20.00 Acrylate / C? 0-C30 crosslinked polymeric alkyl acrylate (marketed under the brand name PEMULEN TR-2 by the company GOODRICH) 0.30 PEG-6 isoterate 2.00 NaOH at 10% is pH 6 In this formulation, the active agent remains stable for at least 3 months at 40 ° C.
EXAMPLE 2 Activity of the formula with clobetasol propionate. The formula according to the invention described above has been taken up with clobetasol propionate as an active agent. The vasoconstriction tests according to a protocol of
Stoughton modified, have been made in comparison with the corresponding A / C cream marketed under the brand TEMOVATE by the company GLAXO. The results show an identical activity for the two formulas, which confirms that despite the change in the viscosity of the formulation according to the invention and the use of a different emulsifier system, the pro-penetrating glycol has retained its pro-active properties. -penetrating. It is noted that in relation to this date, the best method known by the application to carry out the aforementioned invention, is the conventional one for the manufacture of the objects to which it refers. Having described the invention as above, the following is claimed as property:
Claims (15)
- CLAIMS 1. A composition in the form of a fluid emulsion of the oil in water (A / A) type for a topical application, characterized in that it comprises between 30 to 50% by weight with respect to the total weight of the composition of at least one glycol , an appropriate emulsifier system and at least one active agent.
- 2. The composition according to claim 1, characterized in that it has a viscosity comprised between 3 and 10 Pa.s (3000 and 10000 centipoises), viscosity measured with a Brookfield apparatus model LVDV II + mobile no. 4, at a speed of 30 turns / min for 30 seconds and at a temperature of 25 ° C +/- 3 ° C.
- 3. The composition according to one of claims 1 or 2, characterized in that the appropriate emulsifier system comprises at least one polymeric emulsifier.
- 4. The composition according to claim 3, characterized in that the polymeric emulsifier is an anionic amphiphilic polymer, more particularly an anionic amphiphilic polymer comprising at least one hydrophilic radical of the olefinic unsaturated carboxylic acid type, and at least one hydrophobic radical of the ester type of alkyl with C? o ~ C3o.
- 5. The composition according to claim 4, characterized in that the anionic amphiphilic polymers are crosslinked with a polymerizable crosslinking monomer, which contains a group CH2 = C < with at least one other polymerizable group wherein the unsaturated bonds or bonds are non-conjugated with respect to each other, in particular with the polyallyl ethers such as polyallylsucrose and polyallyl pentaerythritol.
- 6. The composition according to one of claims 4 or 5, characterized in that the anionic amphiphilic polymer is chosen from (i) those which are constituted by 95 to 60% by weight of acrylic radicals, from 4 to 40% by weight of radicals acrylates and from 0.1 to 6% by weight of crosslinking monomer, or (ii) those which are comprised of 98 to 96% by weight of acrylic radicals, from 1 to 4% by weight of acrylate radicals and from 0.1 to 0.6% by weight of crosslinking monomer.
- 7. The composition according to one of claims 1 to 6, characterized in that it comprises up to 1% by weight of the appropriate emulsifier system, preferably between 0.2 and 0.4% by weight.
- 8. The composition according to one of claims 1 to 7, characterized in that the pro-penetrating glycol is chosen from propylene glycol, dipropylene glycol, propylene glycol dipelargonate, lauroglycol and ethoxydiglycol.
- 9. The composition according to one of claims 1 to 8, characterized in that it comprises between 40 and 50% by weight of pro-penetrating glycol.
- 10. The composition according to one of claims 1 to 9, characterized in that the active agent is chosen among the agents that modulate differentiation and / or proliferation and / or skin pigmentation, antibacterials, antiparasitics, antifungals, steroidal anti-inflammatory agents or non-steroidal anti-inflammatory agents, anesthetic agents, antipruritic agents, antiviral agents, keratolytic agents, free antiradical agents, anti-seborrheic agents, antipelicular agents, anti-acne agents, antimetabolites, agents to fight against hair loss, and anti-septic.
- 11. The composition according to one of claims 1 to 10, characterized in that it comprises between 0.0001 and 20% by weight with respect to the total weight of the composition of at least one active agent, preferably between 0.025 and 15% by weight.
- 12. The composition according to one of claims 1 to 11, characterized in that the fatty phase is present with a content comprised between 5 and 50% by weight with respect to the total weight of the composition, preferably comprised between 15 and 25% by weight.
- 13. The composition according to one of claims 1 to 12, characterized in that the aqueous phase is present with a content comprised between 10 and 75% by weight with respect to the total weight of the composition, preferably comprised between 20 and 40% by weight.
- 14. The composition according to one of claims 1 to 13, characterized in that it comprises between 0 and 3% by weight with respect to the total weight of the composition, of at least one co-emulsifier, preferably 0 and 2% by weight.
- 15. The composition according to one of claims 1 to 14, characterized in that it comprises at least one gelling agent and / or thickener in the concentrations comprised between 0 and 5% by weight, with respect to the total weight of the composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR96-11510 | 1996-09-20 | ||
FR9611510A FR2753626B1 (en) | 1996-09-20 | 1996-09-20 | NOVEL TOPICAL COMPOSITIONS IN THE FORM OF A FLUID O / W EMULSION WITH A HIGH PRO-PENETRATING GLYCOL CONTENT |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9707140A MX9707140A (en) | 1998-07-31 |
MXPA97007140A true MXPA97007140A (en) | 1998-11-09 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6106848A (en) | Topically applicable O/W emulsions having high glycol content and at least one biologically active agent | |
AU758841B2 (en) | Oil-in-water emulsion comprising a micronized biologically active agent and a suitable emulsifying system | |
EP1104294B1 (en) | Compositions and methods of treating abnormal cell proliferation | |
US8551504B2 (en) | Topical anti-inflammatory compositions comprising O/W emulsions containing pro-penetrating glycols | |
US8551503B2 (en) | Topical anti-inflammatory compositions comprising O/W emulsions containing pro-penetrating glycols | |
JPS5822442B2 (en) | Method for stabilizing tretino ink cream emulsion | |
MXPA97007140A (en) | New topic compositions under the form of fluid emulsion of oil in water with great content of glycol pro-penetra |